ABOS · Acumen Pharmaceuticals, Inc. · Executive Compensation
$1.98
-0.08 (-3.88%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, management has concluded that substantial doubt exists regarding our ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$143.19M
Shares
72.32M
Volume · Oct 23
541.79K
Avg daily vol (3M)
458.35K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Daniel O'Connell | Chief Executive Officer | $1,863,567 |
| Jim Doherty | President and Chief Development Officer | $1,012,859 |
| Matthew Zuga | Chief Financial Officer and Chief Business Officer | $948,789 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Daniel O'Connell | Chief Executive Officer | $4,780,687 |
| Jim Doherty | President and Chief Development Officer | $2,182,081 |
| Matthew Zuga | Chief Financial Officer and Chief Business Officer | $1,689,514 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Daniel O'Connell | Chief Executive Officer | $3,930,011 |
| Matthew Zuga | Chief Financial Officer and Chief Business Officer | $1,606,289 |
| Derek Meisner | Chief Legal Officer | $1,476,637 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Daniel O'Connell | Chief Executive Officer | $2,662,052 |
| Derek Meisner | Chief Legal Officer | $1,279,668 |
| Matthew Zuga | Chief Financial Officer and Chief Business Officer | $1,188,786 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Daniel O'Connell | President and Chief Executive Officer | $1,477,836 |
| Matthew Zuga | Chief Financial Officer and Chief Business Officer | $778,831 |
| Eric Siemers | Chief Medical Officer | $637,906 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Daniel O'Connell | President and Chief Executive Officer | $336,000 |
| Eric Siemers | Chief Medical Officer | $237,600 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Dr. George Golumbeski | Chairman of the Board | Appointed | 2025-11-10 |
| Dr. George Golumbeski | director | Appointed | 2025-11-10 |
| James Doherty | President and Chief Development Officer | Appointed | 2024-02-01 |
| Derrell Porter | director | Appointed | 2023-01-04 |
| Dr. Jeffrey Sevigny | Board of Directors | Resigned | 2022-08-15 |
Leadership
- Daniel O'Connell CEO
- Dr. George Golumbeski Chairman, Board Member
- Matthew Zuga CFO
- Russell Barton COO
- Derrell Porter Board Member